Austar Lifesciences Limited’s (HKG:6118) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Austar Lifesciences Limited (HKG:6118) shares have continued their recent momentum with a 27% gain in the last month alone. Looking back a bit further, it’s encouraging to see the stock is up 79% in the last year.
In spite of the firm bounce in price, Austar Lifesciences’ price-to-sales (or “P/S”) ratio of 0.5x might still make it look like a strong buy right now compared to the wider Life Sciences industry in Hong Kong, where around half of the companies have P/S ratios above 6x and even P/S above 9x are quite common. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments…
